Wegman Mark N 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jul 1, 2009
Insider Transaction Report
Form 4
BIOSPECIFICS TECHNOLOGIES CORPBSTC.NGM
Wegman Mark N
Director
Transactions
- Exercise of In-Money
Common Stock, $0.001 par value
2009-06-29$4.60/sh+15,000$69,000→ 56,494 total - Exercise of In-Money
Stock Option (Right to Buy)
2009-06-29−15,000→ 30,000 totalExercise: $4.60From: 2007-06-25Exp: 2017-06-24→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]This amount includes 37,594 shares of the Issuer's common stock held jointly by the Reporting Person and his wife.
- [F2]The options were granted on June 25, 2007 and vested monthly with respect to 1/12 of the total number of shares until all shares underlying the options vested.